Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Kim

Showing results (61-70 of 269) with videos related to

Pageof 27
Sort By:
Clinics in Liver Disease|May 1, 2012
Evaluation of elevated liver enzymesTae Hoon Lee, W Ray Kim, John J Poterucha
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2019
The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United StatesKarn Wijarnpreecha, Melissa Scribani, Donghee Kim, et al.
Hepatology (Baltimore, Md.)|April 20, 2018
De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral EraAllison J Kwong, W Ray Kim, Jennifer A Flemming
Gastroenterology|April 28, 2011
Born to be wild or just confused? Genetic predisposition to hepatic encephalopathyAndres Duarte-Rojo, Patrick S Kamath, W Ray Kim
Cancer|December 4, 2014
Reply to Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?Jennifer A Flemming, W Ray Kim, Norah A Terrault
JHEP Reports : Innovation in Hepatology|September 18, 2024
Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE scorePimsiri Sripongpun, Apichat Kaewdech, Prowpanga Udompap, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2019
Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide ProphylaxisPimsiri Sripongpun, Ajitha Mannalithara, Paul Y Kwo, et al.
Hepatology (Baltimore, Md.)|July 1, 2020
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision MedicineGeorge V Papatheodoridis, Thodoris Voulgaris, Margarita Papatheodoridi, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United StatesPhil McEwan, Thomas Ward, Yong Yuan, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
Improved posttransplant mortality after share 35 for liver transplantationAllison J Kwong, Aparna Goel, Ajitha Mannalithara, et al.
Pageof 27

Showing results (61-70 of 269) with videos related to

Sort By:
Pageof 27
Clinics in Liver Disease|May 1, 2012
Evaluation of elevated liver enzymesTae Hoon Lee, W Ray Kim, John J Poterucha
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2019
The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United StatesKarn Wijarnpreecha, Melissa Scribani, Donghee Kim, et al.
Hepatology (Baltimore, Md.)|April 20, 2018
De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral EraAllison J Kwong, W Ray Kim, Jennifer A Flemming
Gastroenterology|April 28, 2011
Born to be wild or just confused? Genetic predisposition to hepatic encephalopathyAndres Duarte-Rojo, Patrick S Kamath, W Ray Kim
Cancer|December 4, 2014
Reply to Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?Jennifer A Flemming, W Ray Kim, Norah A Terrault
JHEP Reports : Innovation in Hepatology|September 18, 2024
Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE scorePimsiri Sripongpun, Apichat Kaewdech, Prowpanga Udompap, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2019
Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide ProphylaxisPimsiri Sripongpun, Ajitha Mannalithara, Paul Y Kwo, et al.
Hepatology (Baltimore, Md.)|July 1, 2020
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision MedicineGeorge V Papatheodoridis, Thodoris Voulgaris, Margarita Papatheodoridi, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United StatesPhil McEwan, Thomas Ward, Yong Yuan, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
Improved posttransplant mortality after share 35 for liver transplantationAllison J Kwong, Aparna Goel, Ajitha Mannalithara, et al.
Pageof 27